Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mechanisms of Weight Loss Due to Dual GIP GLP-1 Receptor Agonism With Tirzepatide Compared to Semaglutide: A Randomized Controlled Trial

NCT07900074 is registered in ClinicalTrials.gov with McMaster University as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07900074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Mechanisms of Weight Loss Due to Dual GIP GLP-1 Receptor Agonism With Tirzepatide Compared to Semaglutide: A Randomized Controlled Trial
Lead sponsor
McMaster University
Phase
Phase 4
Overall status
Recruiting
Start date
October 31, 2026
Completion date
December 31, 2029
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity (disorder)

Arms

As registered; 2 arms.

  • Semaglutide ExperimentalSemaglutide

    This group will take semaglutide once weekly for 12 weeks. Participants will be started at 0.25 mg and increase by one dose level every 4 weeks, if tolerated (allowing up to 3 dose levels over 12 weeks), to a maximum dose of 1 mg. Dose levels are 0.25 mg, 0.5 mg, 1 mg.

  • Tirzepatide ExperimentalTirzepatide

    This group will take tirzepatide once weekly for 12 weeks. Participants will be started at 2.5 mg and increase by one dose level every 4 weeks, if tolerated (allowing up to 3 dose levels over 12 weeks), to a maximum dose of 7.5 mg. Dose levels are 2.5 mg, 5 mg, 7.5 mg.

Primary endpoints

Registered primary outcome measures; 1 primary.

  • 24-hour Energy Expenditure Measured Using Whole Room Indirect Calorimetry Baseline, 12 Weeks

    24-hour energy expenditure will be measured using whole room indirect calorimeter. Metabolic rate in kcal/day will be estimated using the Weir formula, from inspired oxygen and expired carbon dioxide measured every minute by software in the Promethium System, summed over 23 hours and extrapolated to 24 hours by multiplying by 24/23.

Lead sponsor's other trials

McMaster University, most recent start first.

Similar trials

Same condition (Weight Loss) and phase, most recent start first.